J.F. Lemeland

492 total citations
26 papers, 350 citations indexed

About

J.F. Lemeland is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, J.F. Lemeland has authored 26 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Infectious Diseases and 6 papers in Pharmacology. Recurrent topics in J.F. Lemeland's work include Antimicrobial Resistance in Staphylococcus (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). J.F. Lemeland is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). J.F. Lemeland collaborates with scholars based in France and Tunisia. J.F. Lemeland's co-authors include G. Humbert, François Caron, Ludwig Gutmann, Marie-Dominique Kitzis, M. Nouvellon, J Leroy, José L. Pons, François Tron, Stéphane Marret and Éric Sélégny and has published in prestigious journals such as Applied and Environmental Microbiology, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

J.F. Lemeland

22 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.F. Lemeland France 10 128 106 93 76 64 26 350
J Barnishan United States 11 143 1.1× 114 1.1× 65 0.7× 112 1.5× 45 0.7× 13 421
B L Wetherall Australia 10 84 0.7× 104 1.0× 54 0.6× 85 1.1× 62 1.0× 15 324
J.M. Scheftel France 10 187 1.5× 75 0.7× 101 1.1× 56 0.7× 51 0.8× 31 371
W. F. DeLorenzo United States 11 77 0.6× 91 0.9× 40 0.4× 62 0.8× 31 0.5× 19 345
Benedict L. Wasilauskas United States 14 96 0.8× 189 1.8× 117 1.3× 45 0.6× 14 0.2× 38 417
Jüri Teras Estonia 7 128 1.0× 69 0.7× 87 0.9× 145 1.9× 14 0.2× 19 404
J. G. M. Hastings United Kingdom 14 214 1.7× 98 0.9× 59 0.6× 44 0.6× 15 0.2× 23 474
Quang Dam United States 5 134 1.0× 56 0.5× 78 0.8× 148 1.9× 39 0.6× 8 408
David Styers United States 6 236 1.8× 92 0.9× 141 1.5× 57 0.8× 26 0.4× 8 460
C. Watanakunakorn United States 11 227 1.8× 159 1.5× 100 1.1× 112 1.5× 10 0.2× 17 515

Countries citing papers authored by J.F. Lemeland

Since Specialization
Citations

This map shows the geographic impact of J.F. Lemeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.F. Lemeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.F. Lemeland more than expected).

Fields of papers citing papers by J.F. Lemeland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.F. Lemeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.F. Lemeland. The network helps show where J.F. Lemeland may publish in the future.

Co-authorship network of co-authors of J.F. Lemeland

This figure shows the co-authorship network connecting the top 25 collaborators of J.F. Lemeland. A scholar is included among the top collaborators of J.F. Lemeland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.F. Lemeland. J.F. Lemeland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hervé, F., N. Cailleux, Y. Benhamou, et al.. (2006). Prévalence des infections à Helicobacter pylori au cours de la maladie de Raynaud. La Revue de Médecine Interne. 27(10). 736–741. 7 indexed citations
2.
Vergnaud, M., Manon Allaire, G Grise, et al.. (2001). Antibiotic resistance of Streptococcus pneumoniae in 1996 and 1997: Normandy regional Observatory results (France). Médecine et Maladies Infectieuses. 31(6). 383–387.
3.
Frébourg, N., et al.. (1997). Evaluation de l'antibiothérapie probabiliste des péritonites post-opératoires en réanimation. Annales Françaises d Anesthésie et de Réanimation. 16(6). 762–762. 1 indexed citations
4.
Fruchart, Christophe, et al.. (1997). Lactobacillus species as emerging pathogens in neutropenic patients. European Journal of Clinical Microbiology & Infectious Diseases. 16(9). 681–684. 31 indexed citations
5.
Nouvellon, M., et al.. (1995). Evaluation of the Epsilometer test (E test) for testing the susceptibility of coagulase-negative staphylococci to teicoplanin. Journal of Antimicrobial Chemotherapy. 36(1). 83–91. 3 indexed citations
7.
Brasseur, Gérard, et al.. (1995). Penicillin-Resistant Streptococcus pneumoniae as a Cause of Postoperative Endophthalmitis. Clinical Infectious Diseases. 21(5). 1340–1341. 2 indexed citations
8.
Thabaut, A, J Avril, Cécile Bébéar, et al.. (1995). Evolution de la sensibilité des bacilles à Gram négatif à la ceftazidime et à trois autres bêta-lactamines en milieu hospitalier de 1989 à 1993. Médecine et Maladies Infectieuses. 25. 6–19. 3 indexed citations
9.
Lemeland, J.F., et al.. (1995). In vitro interactions between different beta-lactam antibiotics and fosfomycin against bloodstream isolates of enterococci. Antimicrobial Agents and Chemotherapy. 39(10). 2341–2344. 9 indexed citations
10.
Lemeland, J.F., et al.. (1994). Epidémiologie moléculaire de la résistance des pneumocoques à la pénicilline. Médecine et Maladies Infectieuses. 24. 944–947. 1 indexed citations
11.
12.
Joly, P., et al.. (1993). [Streptobacillus moniliformis: a rare anthropozoonosis sometimes observed in urban area].. PubMed. 120(11). 813–4. 1 indexed citations
13.
Kaeffer, N., B. Hecketsweiler, J.F. Lemeland, et al.. (1993). L-2-Oxothiazolidine-4-carboxylic acid as a cysteine precursor in acute experimental sepsis in rats: effects on tissue glutathione and cysteine levels. Clinical Nutrition. 12. 17–17. 3 indexed citations
14.
Mejjad, O., A Daragon, Xavier Le Loët, et al.. (1993). [Aspergillus spondylodiscitis. Apropos of 3 cases].. PubMed. 60(1). 45–7. 2 indexed citations
15.
Caron, François, Marie-Dominique Kitzis, Ludwig Gutmann, et al.. (1992). Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium. Antimicrobial Agents and Chemotherapy. 36(12). 2611–2616. 57 indexed citations
16.
Nouvellon, M., et al.. (1992). Infection systémique récidivante à Haemophilus influenzae de type F révélant une hypogammaglobulinémie congénitale. Médecine et Maladies Infectieuses. 22(10). 869–871. 1 indexed citations
17.
Petit, J., H Fouin-Fortunet, V. Colomb, et al.. (1991). Liver factors involved in drug metabolism in experimentally infected rats: deleterious effect of ornithine α-ketoisocaproate. Clinical Nutrition. 10(6). 328–335. 1 indexed citations
18.
Lemeland, J.F., et al.. (1988). Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 32(6). 919–921. 24 indexed citations
19.
Junter, Guy‐Alain, J.F. Lemeland, & Éric Sélégny. (1980). Electrochemical detection and counting of Escherichia coli in the presence of a reducible coenzyme, lipoic acid. Applied and Environmental Microbiology. 39(2). 307–316. 21 indexed citations
20.
Humbert, G., et al.. (1975). Pleurésie purulente à Erysipelothrix insidiosa. Médecine et Maladies Infectieuses. 5(8). 443–444. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026